Glaukos Corporation
GKOS
Hisse Senetlerindeki Sıralama
#2087
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Hisse Fiyatı
$166.79
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$9.84B
Değişim (1 gün)
1.44%
Değişim (1 yıl)
109.88%
Ülke
US
Ticaret Glaukos Corporation (GKOS)
Kategori
Healthcare
Glaukos Corporation (GKOS) için kazanç
Jun 2026 itibarıyla kazanç TTM: $-192.83M
Glaukos Corporation şirketinin en son finansal raporlarına göre, mevcut kazancı $-192.83M'dir. 2023 yılında şirket $-133.73M kazanç elde etti, bu 2022 yılındaki $-98.43M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Glaukos Corporation için kazanç geçmişi 2012 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $-192.83M | 32.44% |
| 2024 | $-145.60M | 8.88% |
| 2023 | $-133.73M | 35.86% |
| 2022 | $-98.43M | 99.79% |
| 2021 | $-49.27M | -62.77% |
| 2020 | $-132.31M | 164.44% |
| 2019 | $-50.04M | 304.56% |
| 2018 | $-12.37M | -1,236,900.00% |
| 2017 | $1.00K | -99.98% |
| 2016 | $4.57M | -111.92% |
| 2015 | $-38.29M | 172.73% |
| 2014 | $-14.04M | -1.28% |
| 2013 | $-14.22M | -35.41% |
| 2012 | $-22.02M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $7.51B | -3,995.08% |
US
|
|
| $5.56B | -2,984.88% |
IE
|
|
| $5.15B | -2,769.67% |
US
|
|
| $3.86B | -2,102.25% |
US
|
|
| - | - |
DE
|
